Femasys (FEMY) Projected to Post Quarterly Earnings on Thursday

Femasys (NASDAQ:FEMY) is projected to announce its results before the market opens on Thursday, March 26th. Analysts expect the company to announce earnings of ($0.0833) per share and revenue of $1.06 million for the quarter.

Femasys Trading Down 2.0%

Shares of FEMY stock opened at $0.51 on Wednesday. Femasys has a fifty-two week low of $0.31 and a fifty-two week high of $1.63. The company has a 50 day moving average price of $0.56 and a 200 day moving average price of $0.63. The stock has a market capitalization of $30.01 million, a P/E ratio of -0.71 and a beta of -2.53. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.61 and a current ratio of 1.16.

Wall Street Analysts Forecast Growth

FEMY has been the subject of several recent research reports. Lake Street Capital started coverage on shares of Femasys in a research report on Tuesday, March 3rd. They issued a “buy” rating and a $1.50 price target for the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Femasys in a research note on Thursday, January 22nd. Finally, Wall Street Zen raised Femasys from a “sell” rating to a “hold” rating in a research note on Saturday, March 7th. Four equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Femasys currently has an average rating of “Moderate Buy” and an average target price of $5.50.

Institutional Trading of Femasys

A number of institutional investors have recently bought and sold shares of the business. Cetera Investment Advisers purchased a new position in Femasys during the 4th quarter worth approximately $36,000. Kovack Advisors Inc. purchased a new position in shares of Femasys during the fourth quarter worth approximately $27,000. State Street Corp grew its position in shares of Femasys by 43.5% during the fourth quarter. State Street Corp now owns 80,869 shares of the company’s stock worth $47,000 after acquiring an additional 24,500 shares during the last quarter. Jane Street Group LLC acquired a new position in shares of Femasys in the 4th quarter valued at $62,000. Finally, HRT Financial LP acquired a new position in shares of Femasys in the 4th quarter valued at $30,000. 65.27% of the stock is owned by hedge funds and other institutional investors.

Femasys Company Profile

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.